Skip to main content
An official website of the United States government

Biometry

Contributes to the rigor and reproducibility of cancer research through statistical consultation and mathematical modeling. Supports research in biostatistical methods and data analytics, machine learning, and artificial intelligence for cancer risk prediction and reduction.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Resources

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Berger, Vance, Ph.D.
vance.berger@nih.gov
240-276-7142
5E628 Statistician | Biometry
Bowles, Heather, Ph.D.
heather.bowles@nih.gov
240-276-6794
5E640 Program Officer | Biometry
Cancer Prevention Fellowship Program
Dodd, Kevin, Ph.D.
kevin_dodd@nih.gov
240-276-7021
5E126 Deputy Chief | Biometry
Hu, Ping, Sc.D.
ping.hu@nih.gov
240-276-7015
5E118 Statistician | Biometry
Morris, Lawrence
lawrence.morris@nih.gov
240-276-7137
5E112 Program Specialist | Biometry
Prorok, Philip C, Ph.D. [C]
philip.prorok@nih.gov
240-276-7131
Contractor | Office of the Director
Biometry
Sirota, Lev, Ph.D. [C]
lev.sirota@nih.gov
240-276-5127
5E114 Contractor | Biometry
Uzzell, Norwood
norwood.uzzell@nih.gov
240-276-7141
5E222 Program Support Assistant | Biometry
Xu, Jian-Lun, Ph.D.
jian-lun.xu@nih.gov
240-276-7023
5E128 Statistician | Biometry

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Cantuaria, Guilherme

Northside Hospital Atlanta
United States

Georgia NCI Community Oncology Research Program (GA NCORP) 3UG1CA189997-11S1 Vanessa A. White, M.P.H.
Cao, Weidan

Ohio State University
United States

Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System 1R01CA301579-01 Eileen Dimond, R.N., M.S.
Cao, Yin

Washington University
United States

PROSPECT-Global Consortium and Risk Factor Discovery 3OT2CA297576-01S1 Asad Umar, D.V.M., Ph.D.
Cao, Shugeng

University Of Hawaii At Hilo
United States

Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors 5UG3CA290375-02 Altaf Mohammed, Ph.D.
Cao, Yin

Washington University
United States

Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia 4R37CA246175-06 Asad Umar, D.V.M., Ph.D.
Carlson, Jay W

Ozark Health Ventures, Llc
United States

Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) 3UG1CA189822-11S1 Vanessa A. White, M.P.H.
Carson, Tiffany Lashaun

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults 5R01CA253219-06 Young Kim, Ph.D.
Castilla, Lucio H.

Univ Of Massachusetts Med Sch Worcester
United States

Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD 1U01CA296350-01 Marjorie Perloff, M.D.
Castro, Cesar M

Massachusetts General Hospital
United States

Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach 3U01CA279858-03S2 Christos Patriotis, Ph.D., M.Sc.
Caulin, Carlos

University Of Arizona
United States

Genetic Alterations That Confer High Risk to Oral Premalignant Lesions 5R01CA274857-04
Caywood, Emi H

Nemours Children'S Hospital, Delaware
United States

Nemours NCI Community Oncology Research Program (NCORP) 3UG1CA189958-11S1 Vanessa A. White, M.P.H.
Chak, Amitabh

Case Western Reserve University
United States

Pathways of Injury and Repair in Barrett's Carcinogenesis 5P01CA269019-03 Asad Umar, D.V.M., Ph.D.
Chan, Alexandre

University Of California-Irvine
United States

Neurotrophic strategy to mitigate chemotherapy-related brain injury 5R01CA276212-03 John Clifford, Ph.D.
Chan, Andrew T

Massachusetts General Hospital
United States

MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297680-01S1 Asad Umar, D.V.M., Ph.D.
Chan, Daniel Wanyui

Johns Hopkins University
United States

Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions 5U01CA274514-03 Matthew Young, Ph.D.